Trial Profile
Clinical Trials Insight: 700058116
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2010
Price :
$35
*
At a glance
- Drugs Obatoclax (Primary)
- Indications Small cell lung cancer
- Focus Registrational; Therapeutic Use
- Sponsors Gemin X Pharmaceuticals
- 05 Aug 2010 New trial record